High-purity Semaglutide research compound. GLP-1 receptor agonist studied in metabolic regulation, glucose homeostasis, and energy balance research models.
Semaglutide is a long-acting GLP-1 (glucagon-like peptide-1) receptor agonist research compound. Originally developed as a synthetic analog of human GLP-1, it features structural modifications that significantly extend its half-life compared to native GLP-1.
As a GLP-1 receptor agonist, Semaglutide binds with high affinity to the GLP-1 receptor expressed on pancreatic beta cells, gastrointestinal tract, and CNS neurons. Research has investigated its effects on glucose-dependent insulin secretion, gastric emptying delay, and central pathways involved in satiety signaling.
Semaglutide is used in research investigating: glucose metabolism and insulin signaling, satiety and food intake regulation, lipid metabolism pathways, cardiovascular research models, neuroprotective signaling studies, and PK/PD studies of long-acting peptide analogs.
| Compound | Semaglutide |
| Available Strengths | 2mg, 5mg, 10mg, 15mg, 20mg, 30mg |
| Purity | ≥99% (verified by HPLC) |
| Form | Lyophilized powder |
| Storage | -20°C, protected from light |
| Reconstitution | Bacteriostatic water (sold separately) |
| Shelf Life | 36 months (lyophilized, properly stored) |
| Certificate of Analysis | Available upon request — contact us |
Add bacteriostatic water slowly. Use within 28 days.
Lyophilized: -20°C. Reconstituted: 2-8°C.
For research use only. Not for human consumption.